mRNA |
PHA-793887 |
GDSC1000 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
BIX02189 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.02 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
BMS-754807 |
GDSC1000 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.02 |
mRNA |
PI-103 |
CTRPv2 |
pan-cancer |
AAC |
0.085 |
0.02 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
CHM-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.087 |
0.02 |